Economic evaluation of a combined DTPa, hepatitis B, polio, Hib vaccine

Abstract

A new hexavalent combination vaccine, Infanrix-HEXA, including a recombinant hepatitis B vaccine in addition to the vaccines for diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type B, has recently become available in France. The objectives of this study were to: (1) estimate the break-even price of Infanrix-Hexa for the National… (More)
DOI: 10.1007/s10198-003-0216-z

4 Figures and Tables

Topics

  • Presentations referencing similar topics